flavodilol has been researched along with Hypertension in 2 studies
*Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gens, J; Hill, NE; Mookherjee, S; Smulyan, H; Vardan, S; Willsey, GA | 1 |
| Borrelli, AR; Kaiser, FC; Kinsolving, CR; Watkins, BE; Wu, ES | 1 |
2 other study(ies) available for flavodilol and Hypertension
| Article | Year |
|---|---|
Importance of intraarterial blood pressure measurement in the evaluation of a new antihypertensive agent and the need to define hypertension also by this method.
Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Flavonoids; Humans; Hypertension; Male; Middle Aged | 1990 |
Flavodilol: a new antihypertensive agent.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Autonomic Nervous System; Biogenic Amines; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Flavonoids; Hypertension; Indomethacin; Male; Rats; Rats, Inbred SHR; Spinal Cord; Sulpiride | 1989 |